NKGen Biotech, Inc. (NKGN)

OTCMKTS · Delayed Price · Currency is USD

0.0370

0.00 (0.00%)

At close: Dec 5, 2025

NKGen Biotech Employees

NKGen Biotech had 26 employees as of December 31, 2024. The number of employees decreased by 37 or -58.73% compared to the previous year.

Employees

26

Change (1Y)

-37

Growth (1Y)

-58.73%

Revenue / Employee

n/a

Profits / Employee

-$1,703,308

Market Cap

4.60M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	26	-37	-58.73%
Dec 31, 2023	63	-	-

Related Stocks

Company Name	Employees
Elite Pharmaceuticals	68
Glass House Brands	374
CytoDyn	13
American Oncology Network	1,914
Northwest Biotherapeutics	25
Silence Therapeutics	116
Zomedica	152

Employee Rankings

NKGen Biotech News

2 months ago - NKGen Biotech (NKGN) Clarifies OTC Market Trading Status Amid Quoting Limitations - GuruFocus
2 months ago - NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market - GlobeNewsWire
2 months ago - NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the XXVII World Congress of Neurology - GlobeNewsWire
2 months ago - NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum - GlobeNewsWire
3 months ago - NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets - GlobeNewsWire
4 months ago - NKGen Biotech To Present on Allogeneic Enhanced NK Cells without Lymphodepletion in Solid Tumors at the 13th Annual Immuno-Oncology Summit - GlobeNewsWire
4 months ago - NKGen Biotech Presents Troculeucel Mechanism of Action with Corresponding Phase 1 Biomarker Data at the Alzheimer's Association International Conference 2025 - GlobeNewsWire
4 months ago - NKGen Biotech to Present at the Alzheimer's Association International Conference 2025 - GlobeNewsWire